• 13 February 2019

    Edwards Lifesciences to buy CASMED for $100m

    Edwards Lifesciences has signed a definitive agreement to acquire medical technology company CAS Medical Systems (CASMED) in an all-cash transaction valued at around $100m, or $2.45 per share.

  • 29 January 2019

    Sensyne Health to use AI for chronic disease management

    UK-based Sensyne Health has formed a research collaboration alliance with the University of Oxford’s Big Data Institute (BDI) for the development and assessment of clinical artificial intelligence (AI) and digital...

Go Top